Improving surgical resection rates in lung cancer without a two stop service

Open Access
Publisher Website
Google Scholar
Abstract
The development of chemotherapy for NSCLC over the last 20 years is reviewed, particularly with regard to its palliative effects. New “fourth generation” agents designed to inhibit specific biological pathways thought to be crucial to tumour growth give cause for optimism in the future treatment of NSCLC.

This publication has 0 references indexed in Scilit: